CME Group is launching federal legal action against the CFTC following the regulator’s approval of crypto perpetual futures contracts in the United States. Outgoing CEO Terrence Duffy confirmed the exchange will challenge the Commission’s authorisation of Kalshi’s BTCPERP product and a related no-action letter granted to Coinbase, claiming the agency bypassed mandatory review procedures for novel and complex instruments.
The dispute centers on product classification. CME contends that perpetual futures, which have no expiry date and rely on periodic funding rates between position holders, should be regulated as swaps under Dodd-Frank rather than futures. If courts accept this argument, crypto perps would face substantially more stringent compliance requirements including mandatory clearing, dealer registration obligations, and enhanced margin rules. Duffy also asserts that CME holds exclusive benchmark licensing rights that would legally require such contracts to clear through its infrastructure.
The litigation carries significant implications for US-based crypto derivatives platforms. A favorable ruling for CME would impose substantial regulatory and operational burdens on recently launched perpetual products from Kalshi, Coinbase, and Kraken, potentially reshaping competitive dynamics in the domestic digital asset derivatives market. The case also raises systemic risk questions around high leverage ratios commonly offered on crypto exchanges, contrasting sharply with traditional futures market safeguards.
For brokers and fintech firms eyeing US crypto derivatives expansion, this legal battle introduces meaningful regulatory uncertainty regarding product structure and authorisation pathways.
FXnCO Insight
Any firm planning US crypto derivatives offerings should pause rollout plans until this classification dispute resolves, as swap designation would fundamentally alter compliance architecture and market access routes.
Source: Finance Magnates